Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Adma Biologics Inc (NASDAQ: ADMA) closed the day trading at $3.57M up 6732869% from the previous closing price of $18.13. In other words, the price has increased by $6732869 from its previous closing price. On the day, 6.73 million shares were traded. ADMA stock price reached its highest trading level at $18.1934 during the session, while it also had its lowest trading level at $17.69.
Ratios:
For a better understanding of ADMA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.72. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 16 ’25 when Grossman Adam S sold 21,000 shares for $20.81 per share. The transaction valued at 437,010 led to the insider holds 2,043,850 shares of the business.
ELMS STEVE sold 194,749 shares of ADMA for $3,941,720 on Jun 16 ’25. The Director now owns 87,330 shares after completing the transaction at $20.24 per share. On Jun 13 ’25, another insider, ELMS STEVE, who serves as the Director of the company, sold 137,931 shares for $20.82 each. As a result, the insider received 2,871,723 and left with 282,079 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4235141120 and an Enterprise Value of 4245533440. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.02, and their Forward P/E ratio for the next fiscal year is 18.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.22 while its Price-to-Book (P/B) ratio in mrq is 11.33. Its current Enterprise Value per Revenue stands at 9.242 whereas that against EBITDA is 26.544.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.48, which has changed by 0.61126244 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $10.21. The 50-Day Moving Average of the stock is -14.94%, while the 200-Day Moving Average is calculated to be -5.79%.
Shares Statistics:
Over the past 3-months, ADMA traded about 3.57M shares per day on average, while over the past 10 days, ADMA traded about 3754500 shares per day. A total of 238.53M shares are outstanding, with a floating share count of 230.52M. Insiders hold about 3.48% of the company’s shares, while institutions hold 86.39% stake in the company. Shares short for ADMA as of 1748563200 were 14312460 with a Short Ratio of 4.01, compared to 1745971200 on 12347771. Therefore, it implies a Short% of Shares Outstanding of 14312460 and a Short% of Float of 7.359999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
